Skip to main content

Ventilators Market: Global Trends, Growth Drivers & Industry Outlook

Page 1

Global Opportunity Analysis I n du st r y F o r ec a st 2024 – 2030

ICU mechanical ventilation — hospitals & clinics remain the anchor end-user

Ventilators Market From pandemic surge to structural demand — a USD 10.08 billion respiratory-care equipment opportunity by 2030.

USD 6.21 Bn

7.2% CAGR 2024 – 2030

USD 10.08 Bn

Market value

Forecast value

2023

2030

Executive Summary USD 3.87 Bn of incremental revenue is added by 2030 at a 7.2% CAGR — capitalequipment growth with recurring consumable and service pull-through. Demand is structural, not episodic: WHO recorded ~4.1 Mn respiratory-disease deaths (2021) and ~10 Mn TB cases (2020), sustaining installed-base volumes. North America holds the dominant share; Asia-Pacific is the growth engine on geriatric burden and low-cost device localisation. Copyright © Next Move Strategy Consulting

Source: NMSC Ventilators Market report


01 · Market Landscape

Market Size, Share & Ecosystem

+62% cumulative growth

Revenue trajectory, 2023 – 2030

USD 3.87 Bn added

USD billion · global ventilators market 12

8

6.21

7.66

10.08

8.80

7.2% CAGR 2024–30

4

0

2023

2026*

2028*

2030

* Interim years modelled by NMSC on the reported 7.2% CAGR; 2023 actual and 2030 forecast are reported values.

Regional standing

Industry ecosystem

Qualitative rank per NMSC geographic analysis

Segmentation spine of the report

North America — dominant share

TYPE

MODE

Adult · Neonatal / Pediatric

Volume · Pressure · Combined

INTERFAC E

MOBIL ITY

Europe — mature installed base

Invasive · Non-invasive

Intensive care · Transportable

RoW — LATAM, MEA emerging

END - U SER

Asia-Pacific — steady growth

Hospitals & clinics · Ambulatory care · EMS · Rehabilitation · Home care

What the numbers mean

Post-COVID normalisation is already priced in. The 2023 base of USD 6.21 Bn sits past the surge peak, so the 7.2% CAGR is replacement- and upgrade-led. Five end-user channels de-risk the revenue mix — hospital capex cycles are balanced by ambulatory, EMS, rehabilitation and home-care demand. Restraint to underwrite: ventilator-associated infection risk is the report's named brake — closed-suction and disinfection design is the mitigation.

Copyright © Next Move Strategy Consulting

Source: NMSC Ventilators Market report · WHO


02 · Growth Thesis

Growth Drivers & Opportunities Demand drivers — the epidemiological floor under the forecast

4.1 Mn

10 Mn

30.8 Mn

504,000

Respiratory-disease

Tuberculosis cases

U.S. adults smoking

TB deaths in India, 2021

deaths worldwide, 2021

globally, 2020

cigarettes, 2020

Fuels elimination

WHO — chronic ventilation

5.6 Mn men · 3.3 Mn women

CDC — COPD pipeline

programme spend

base

High-growth segments

Regional opportunity map

Relative momentum vs. market average (7.2%)

Where the incremental USD 3.87 Bn is contested

Non-invasive ventilation (PAP / BiPAP) Home-care settings

North America

Transportable ventilators & EMS

Dominant

Europe Mature RoW

Neonatal / pediatric ventilators

AsiaPacific Steady growth LATAM · Middle East · Africa — emerging

Bubble size = relative revenue share; ring colour = regional role in Bar length = NMSC qualitative momentum ranking from report

the growth thesis. Schematic, not to geographic scale.

segment commentary; not a reported segment CAGR.

Where to play PAP innovation is the primary driver. APAP and BiPAP advances move respiratory support out of the ICU into step-down and home settings, expanding unit volumes. Connected portables open a software-attached line. Cloud-connected Trilogy and VITAE 40 class devices make remote monitoring a monetisable layer above hardware. Ambulatory cardiac surgery is the named white space — rising surgical volumes in a channel with faster procurement cycles than tertiary hospitals. Asia-Pacific needs a cost-engineered SKU. Locally built units near INR 10,000 reset the price expectation that premium-only portfolios must answer.

Hospital ICU platforms remain the installed-base anchor — growth accrues at the transportable and home-care edge.

Copyright © Next Move Strategy Consulting

Source: NMSC report · WHO · U.S. CDC


03 · Competitive Scenario

Who Holds the Field Competitive positioning matrix

10 profiled players competing on acquisition & product launch

Portfolio breadth vs. care-setting reach · NMSC assessment Focused specialists

Full-spectrum leaders

Koninklijk e Philips GEN.V. HealthCare

Hamilton Medical Vyaire Medical Drägerwerk

Fisher & Paykel Healthcare

ZOLL Medical

Medtronic

ResMed

Smiths Group

Ca reset tin g rea ch: ac ut e → ho me →

Niche / adjacent entrants

Broad-line challengers

Portfolio breadth (ICU · transport · neonatal · non-invasive) → Acute / ICU platform incumbents

Non-invasive & home-care led

Emergency / transport

Placement reflects NMSC qualitative assessment of reported portfolio and channel coverage; axes are not revenue-scaled.

Key strategies — what the leaders actually did M&A · April 2021

Launch & capacity · April 2020

ZOLL Medical acquires Respicardia

Philips launches Respironics E30

Adds the remedē System — the only FDA-approved

Scaled to 15,000 units per week and expanded

implantable for central sleep apnea, a condition tied to

hospital assembly lines — supply-chain capacity used

heart failure and arrhythmia.

as a competitive weapon.

Read-through for investors

Consolidated, not concentrated. Ten credible global players compete across four segmentation axes — scale sits in service networks and regulatory portfolios. Acquisition is the default entry route into adjacent respiratory therapy — sleep apnea and implantable neurostimulation are being bought, not built. White space for challengers: cost-engineered transportable units for Asia-Pacific and EMS have the thinnest incumbent coverage.

Copyright © Next Move Strategy Consulting

Source: NMSC Ventilators Market report


04 · Decision Layer

Strategic Implications One market view, three decision agendas Potential investors

Underwrite durability, not upside. A mid-single-digit CAGR on essential

7.2%

critical-care equipment is a defensive growth profile — attractive where

CAGR to 2030 on a

year earnings. Preferred exposure: non-invasive and home-care-weighted platforms,

USD 6.21 Bn base

the entry multiple reflects post-COVID normalisation rather than surge-

where unit-volume expansion sits and where connected-device data creates recurring revenue above the hardware line. Internal strategy

Build the cost-engineered SKU deliberately. Asia-Pacific price anchors

5

set by locally built low-cost units make a premium-only portfolio

end-user channels to cover, not one

structurally unable to convert the region's growth. Treat infection risk as a roadmap item. Ventilator-associated infection is the report's named restraint — closed-suction, sensing and disinfection design turns a market brake into a differentiation claim.

B2B decision-makers

Negotiate on capacity, not list price. The 15,000 units/week ramp

10

demonstrated in 2020 proved that assured supply — not unit economics —

qualified global supply partners

is the scarce commodity in a demand shock. Specify interoperability up front. Cloud-connected platforms shift total cost of ownership toward monitoring, service and data integration across the acute-to-home continuum.

Watch list

Report toolkit included

Restraint: infection via artificial airway.

SWOT analysis · Porter's Five Forces · value-chain analysis mapping stakeholder roles · competitive market-share analysis · quantitative estimations through 2030.

Base effect: surge-era installed base delays replacement cycles. Price pressure: low-cost regional entrants in AsiaPacific.

Bottom line

The market's next USD 3.87 billion is won at the edge — noninvasive, transportable and home-care — not in the ICU it was built in.

Copyright © Next Move Strategy Consulting

Source: NMSC Ventilators Market report


Ventilators Market · 2024 – 2030

Thank You Let's turn this market view into your decision. Connect with our

analysts for segment-level sizing, competitor benchmarking and goto-market strategy tailored to your investment or growth mandate. Access the complete report

nextmsc.com/report/ventilators-market

Get in touch Website

P h on e

www.nextmsc.com

+1 857 758 5017

Email

C ov e r a g e

info@nextmsc.com

Semiconductor & Electronics practice

Follow us

in

f

LinkedIn

Facebook

/company/next-movestrategy-consulting

Next-Move-StrategyConsulting

Copyright © Next Move Strategy Consulting

X

◎

YouTube

Twitter / X

Instagram

/channel/UCJuVRxfBoDsog7BgDE4uPQ

twitter.com/ nextmsc

instagram.com/ nextmsc

Source: NMSC Ventilators Market report


Turn static files into dynamic content formats.

Create a flipbook
Ventilators Market: Global Trends, Growth Drivers & Industry Outlook by sanchita2233 - Issuu